FRA
Front Row Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-200
| Closed | -$3.25K | – | 809 |
|
2024
Q2 | $3.25K | Hold |
200
| – | – | ﹤0.01% | 799 |
|
2024
Q1 | $2.82K | Buy |
+200
| New | +$2.82K | ﹤0.01% | 806 |
|
2023
Q4 | – | Sell |
-200
| Closed | -$2.04K | – | 776 |
|
2023
Q3 | $2.04K | Hold |
200
| – | – | ﹤0.01% | 813 |
|
2023
Q2 | $2K | Hold |
200
| – | – | ﹤0.01% | 824 |
|
2023
Q1 | $2K | Hold |
200
| – | – | ﹤0.01% | 840 |
|
2022
Q4 | $2K | Hold |
200
| – | – | ﹤0.01% | 806 |
|
2022
Q3 | $2K | Hold |
200
| – | – | ﹤0.01% | 839 |
|
2022
Q2 | $2K | Hold |
200
| – | – | ﹤0.01% | 847 |
|
2022
Q1 | $2K | Hold |
200
| – | – | ﹤0.01% | 876 |
|
2021
Q4 | $2K | Hold |
200
| – | – | ﹤0.01% | 892 |
|
2021
Q3 | $2K | Hold |
200
| – | – | ﹤0.01% | 882 |
|
2021
Q2 | $2K | Hold |
200
| – | – | ﹤0.01% | 884 |
|
2021
Q1 | $2K | Hold |
200
| – | – | ﹤0.01% | 884 |
|
2020
Q4 | $2K | Hold |
200
| – | – | ﹤0.01% | 844 |
|
2020
Q3 | $2K | Hold |
200
| – | – | ﹤0.01% | 842 |
|
2020
Q2 | $2K | Hold |
200
| – | – | ﹤0.01% | 872 |
|
2020
Q1 | $2K | Hold |
200
| – | – | ﹤0.01% | 848 |
|
2019
Q4 | $2K | Hold |
200
| – | – | ﹤0.01% | 809 |
|
2019
Q3 | $1K | Hold |
200
| – | – | ﹤0.01% | 883 |
|
2019
Q2 | $2K | Sell |
200
-702
| -78% | -$7.02K | ﹤0.01% | 865 |
|
2019
Q1 | $14K | Buy |
902
+401
| +80% | +$6.22K | 0.01% | 389 |
|
2018
Q4 | $8K | Sell |
501
-285
| -36% | -$4.55K | 0.01% | 448 |
|
2018
Q3 | $16 | Sell |
786
-3
| -0.4% | – | 0.01% | 340 |
|
2018
Q2 | $18 | Buy |
789
+251
| +47% | +$6 | 0.01% | 347 |
|
2018
Q1 | $9K | Sell |
538
-6
| -1% | -$100 | 0.01% | 458 |
|
2017
Q4 | $10K | Buy |
+544
| New | +$10K | 0.01% | 436 |
|